Healthcare information provider Wolters Kluwer Health, US, has extended its global distribution agreement with the New England Journal of Medicine (NEJM.org), a publisher of breakthrough biomedical research and best practices in clinical medicine, to be the exclusive provider of NEJM site licenses in China. Under the terms of the new agreement, Ovid, part of Wolters Kluwer Health, will be the exclusive provider of NEJM site licenses in China providing access to content upon publication on either Ovid or NEJM.org platforms as well as access to the NEJM archive on NEJM.org.
In addition, Ovid will continue to provide access to current NEJM content to institutions globally through the Ovid platform. Ovid customers will have site-wide access to current issues of the New England Journal of Medicine back through 1990 in PDF format, plus links to NEJM's Online First articles.
Ovid is a global information solutions provider offering clinicians, researchers, and students in the medical, scientific, and academic fields customisable solutions of trusted, evidence-based content, and tools and services that make research smarter, faster, and more effective. Ovid's research platform is used by more than 12,500 institutions worldwide.
The New England Journal of Medicine (NEJM.org), the world's leading medical journal and website, is a publication of NEJM Group, a division of the Massachusetts Medical Society. Founded in 1812, NEJM publishes peer-reviewed research and interactive clinical content for physicians, educators and the global medical community.
